U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07337096) titled 'Electro-Acupuncture in Lung cancER : EALER Study' on Dec. 09, 2025.
Brief Summary: This multicentre, randomized controlled trial evaluates the effect and safety of acupuncture combing with PD-1 inhibitors plus chemotherapy in NSCLC. Participants will be randomly assigned to undergo either acupuncture or sham acupuncture concurrent with the initial four-six cycles of chemotherapy combined with PD-1 inhibitors.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Non Small Cell Lung Cancer
Accupuncture
PD-1 Inhibitors
Intervention:
OTHER: Acupuncture
Acupuncture at Neiguan(PC6), Zhongwan (CV12), Guanyuan (CV 4), B...